Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose
Clinical trial NCT04715230 · TERMINATED
Trial details
- NCT number
- NCT04715230
- Sponsor
- InterveXion Therapeutics, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-30
- Primary completion
- 2022-10-05
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.